Steven S Good

4PUBLICATIONS
3CO-AUTHORS
Medical virologyMedical molecular engineering of nucleic acids and proteinsCheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 24, 2022
AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model.

Kai Lin, Steven S Good, Justin G Julander

|Aug 23, 2021
Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with In Vitro and In Vivo Activity against Dengue and Other Flaviviruses.

Steven S Good, Ashleigh Shannon, Kai Lin

|Feb 09, 2021
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19.

Steven S Good, Jonna Westover, Kie Hoon Jung

|Jan 09, 2020
Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.

Steven S Good, Adel Moussa, Xiao-Jian Zhou

Pageof 1

Frequent Collaborators

1 joint publications

Justin G Julander

1 joint publications

Kai Lin

1 joint publications

Abbie E Weight